• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    AbbVie Inc. (ABBV)

    -NYSE
    60.35 Down 2.77(4.39%) 4:00PM EST
    |After Hours : 60.35 0.00 (0.00%) 4:38PM EST
    Add to Portfolio
    Prev Close:63.12
    Open:62.08
    Bid:60.30 x 100
    Ask:60.35 x 600
    1y Target Est:70.43
    Beta:1.82
    Next Earnings Date:30-Jan-15ABBV Earnings announcement
    Day's Range:60.12 - 62.68
    52wk Range:45.50 - 70.76
    Volume:17,575,064
    Avg Vol (3m):7,354,690
    Market Cap:96.15B
    P/E (ttm):26.24
    EPS (ttm):2.30
    Div & Yield:1.96 (3.10%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 4.39%96.15B
    MRKDown 2.92%171.85B
    NVSDown 1.77%233.63B
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):13.81
    P/S (ttm):5.13
    Ex-Dividend Date:13-Jan-15

    Analysts

    Annual EPS Est (Dec-14) :3.30
    Quarterly EPS Est (Dec-14) :0.86
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.24

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback